0001127602-23-004886.txt : 20230213
0001127602-23-004886.hdr.sgml : 20230213
20230213163910
ACCESSION NUMBER: 0001127602-23-004886
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221231
FILED AS OF DATE: 20230213
DATE AS OF CHANGE: 20230213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Sean C.
CENTRAL INDEX KEY: 0001801993
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 23619178
MAIL ADDRESS:
STREET 1: C/O VERICEL CORPORATION
STREET 2: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
5
1
form5.xml
PRIMARY DOCUMENT
X0306
5
2022-12-31
0
0
0000887359
Vericel Corp
VCEL
0001801993
Flynn Sean C.
C/O VERICEL CORPORATION
CAMBRIDGE
MA
02139
1
SVP, General Counsel
Common Stock
2022-03-31
5
A
0
215
32.49
A
3660
D
Common Stock
2022-06-30
5
A
0
403
21.40
A
4063
D
Common Stock
2022-09-30
5
A
0
25
19.72
A
4088
D
Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Sean Flynn
2023-02-13